Antibiotic resistance is one of the biggest threats facing us today!
European Antibiotic Awareness Day (EAAD) is part of the UK 5 Year Antimicrobial Resistance Strategy 2013 to 2018, which focuses on antibiotics and sets out actions to slow the development and spread of antimicrobial resistance.
This year, to run in line with EAAD; Public Health England has established the Antibiotic Guardian pledge campaign. It calls on everyone in the UK, the public and healthcare community to become antibiotics guardian by choosing one simple pledge about how they will make better use of these vital medicines.
To ensure that the information and knowledge on Antibiotic Stewardship is disseminated to those practising healthcare across the nation, a series of awareness and educational events have been developed. These educational workshop events, to be held in Leeds, Birmingham and London, will provide guidance, resources and information for practitioners on topics associated with antibiotic awareness. The events will provide an opportunity to understand how you and your organisation can support combat the global challenge faced by antibiotic resistance whilst gaining advice, support and resources to inform patients and staff.
2. Chairs introduction
Dr Cliodna McNulty, Head, PHE Primary Care Unit
& Consultant Medical Microbiologist, and Honorary
Visiting Professor Cardiff University, National
Infection Service, Public Health England
4. Disclaimer
⢠I am a âtopic expert memberâ for guideline on
âAntimicrobial stewardship: Changing risk-
related behaviours in the general populationâ
⢠I am not a NICE employee
⢠NICE has not had prior sight or approval of this
presentation
6. The background: why NICE was
set up
⢠Established in 1999
⢠Aim: to reduce variation in the
availability and quality of
treatments and care (the so
called âpostcode lotteryâ)
⢠To resolve uncertainty about
which medicines and
treatments work best and
which represent best value for
money for the NHS
8. Core principles of NICEâs work
⢠Based on the best evidence available
⢠Expert input
⢠Patient and carer involvement
⢠Independent advisory committees
⢠Genuine consultation
⢠Regular review
⢠Open and transparent process
⢠Social values and equity considerations
10. Guideline still in draft
⢠Guideline has been in development for
about 18 months
⢠Public consultation on guidance:
8 September to 20 October 2015
⢠Expected date of issue:
March 2016
11. Scope
⢠Interventions to change publicâs behaviour
to reduce development of AMR and stop
spread of resistant microbes
â Includes measures to raise awareness and
knowledge
â Includes measures to prevent and control
infection
12. Target audience
⢠Those with responsibility for prescribing and
dispensing antimicrobials
⢠Those in public health
⢠Those who give information and advice to the
public
⢠Those responsible for preventing and controlling
infections
⢠The public themselves â especially vulnerable
groups
13. Seven areas of
recommendation
1. National and local information
campaigns
2. Public interventions to prevent
infection
3. Interventions to reduce inappropriate
antimicrobial demand and use
4. Childcare settings
5. Schools
6. Educational and residential settings
for young adults
7. Healthcare settings
Setting-specific
recommendations
14. 1. National and local information
campaigns
⢠Raise awareness of AMR
⢠Give info on preventing and controlling
infections
⢠Using range of modes of delivery (verbal
advice, multimedia, written, mass media)
15. 2. Public interventions to
prevent infection
⢠Advice on handwashing (including when
and how to wash hands; when hand
sanitisers are / are not appropriate)
⢠Food hygiene advice
⢠Wider aspects of infection prevention
(such as the need for vaccinations)
16. 3. Reduce inappropriate
antimicrobial demand and use
⢠Educating the public about the natural
course of self-limiting conditions (including
red-flag symptoms)
⢠Educating the public about where to seek
help/advice if/when they need it (e.g. use
pharmacies rather than A&E)
⢠Advising people to use prescribed
antimicrobials appropriately
17. 4. Childcare settings
⢠Clean appropriately, and train staff in
cleaning appropriately
⢠Provide handwashing facilities
⢠Educate children about handwashing,
involving parents and carers
⢠Ensure parents and carers are aware of
the importance of preventing AMR
18. 5. Schools
⢠Take a âwhole-schoolâ approach
⢠Provide handwashing facilities, and teach
handwashing in an age-appropriate way
⢠Use teaching resources such as PHEâs âe-
bugâ to educate children about microbes
and AMR
⢠Consider integration wider messages
⢠Consider involving parents and carers
19. 6. Educational and residential
settings for young adults
⢠Awareness raising activities, including
about handwashing (with posters in
strategic locations) and food-safety
campaigns
⢠Raise awareness about other aspects of
infection prevention (e.g. vaccinations)
⢠Help students to understand about self-
care and where to seek help
20. 7. Healthcare settings
⢠Give advice about self-limiting conditions,
including natural course and where to seek help
⢠Consider using decision-support aids to
encourage health professionals not to prescribe
antibiotics for self-limiting conditions
⢠When not prescribing antibiotics, explain why,
and give written information including safety-
netting advice
⢠When prescribing antibiotics, explain why, and
give written information on antibiotics
22. Overarching implementation
⢠Consider developing a local area
antimicrobial stewardship strategy linking
public health, local authorities, healthcare,
and social care.
25. Scope
⢠Effective use of antimicrobials as part of all
publically funded health and social care
commissioned or provided by NHS
organisations, local authorities (in
England), independent organisations or
independent contractors.
26. Recommendations for:
⢠Organisations (commissioners and providers)
â Establish antimicrobial stewardship programme
â Establish antimicrobial stewardship team
â Further specific recommendations around
communication, interventions, and lab testing
⢠Prescribers and practitioners
â Specific guidelines for prescribing antimicrobials
⢠Introduction of new antimicrobials
29. NICE Pathways- guidance at
your fingertips
Pathways brings
together all
NICE guidance,
quality standards
and support in
easy-to-navigate
flowcharts
pathways.nice.org.uk
30. NICE guidance and BNF apps for your
iPhone or smartphone
Search over 750 pieces of
NICE guidance, including
Public health guidance.
Download it today for free
from Appleâs App Store
and Google Play.
BNF apps available free with
Athens password.
31. Follow us on Twitter
@NICEcomms
Subscribe online to NICE News, our
monthly newsletter - containing
information about new guidance,
quality standards and
implementation resources launched
each month.
Sign up at:
www.nice.org.uk/newsletter
Keep up to date with the latest from NICE...
32. Get involved
Did you know you canâŚ
⢠Join a NICE Committee- use your expertise to
support development of our guidance
⢠Comment on a Consultation- feedback on
scope and drafts of guidance and quality
standards
⢠Join our Fellows and Scholars programme- a
growing group of professionals benefitting from
NICE sponsorship and mentoring
⢠www.nice.org.uk/getinvolved
35. Section Title
âThere is the danger that
the ignorant man may
easily under dose himself
and by exposing his
microbes to non-lethal
quantities of the drug make
them resistant.â
Antibiotic resistance neither unexpected
or new
36. Hunter-gatherers host more diverse bacteria than humans in
industrialized nations.
When scientists first made contact with an
isolated village of Yanomami hunter-
gatherers in the remote mountains of the
Amazon jungle of Venezuela in 2009, they
marveled at the chance to study the health
of people who had never been exposed to
Western medicine or diets. But much to
their surprise, these Yanomamiâs gut
bacteria have already evolved a diverse
array of antibiotic-resistance genes,
according to a new study, even though
these mountain people had never
ingested antibiotics or animals raised
with drugs. The find suggests that
microbes have long evolved the capability
to fight toxins, including antibiotics, and
that preventing drug resistance may be
harder than scientists thought.
Resistance to antibiotics found in
isolated Amazonian tribe
Article in Science 17th April 2015
39. Fighting antimicrobial resistance
stimulate production of new
antibiotics â new payment models
need accurate record keepingneed more new antibiotics
reduce antibiotic use in farming/food production
40. Fighting antimicrobial resistance
stimulate production of new
antibiotics â new payment models
need accurate record keepingneed more new antibiotics
reduce antibiotic use in farming/food production
41. The World Health Organisation
âthe cost effective use of antimicrobials which maximises clinical
therapeutic effect while minimising both drug-related toxicity and the
development of antimicrobial resistanceâ
Chief Medical Officer
âembodies an organisational or healthcare-system-wide approach to
promoting and monitoring judicious use of an to preserve their effectâ
We need to
- optimise therapy for an individual
- prevent overuse, misuse and abuse
- minimise the development of resistance at patient and community
levels
What is antimicrobial stewardship?
42.
43. The role of community pharmacists in
antimicrobial stewardship
Recognising signs of infection
⢠fever, aches, pain
⢠presence of pus, swelling, and/or redness in a potentially
infected site
⢠confusion, of sudden onset, particularly in older people
⢠drowsiness, irritability, poor appetite in children
Determining the duration of symptoms (e.g. cough, sore throat) and whether
the patientâs condition is improving or deteriorating
Manage patients expectations & refer patients to the GP only when absolutely
necessary (80% of antibiotics prescribed in primary care)
44. The role of community pharmacists in
antimicrobial stewardship
Recognising signs of infection
⢠fever, aches, pain
⢠presence of pus, swelling, and/or redness in a potentially
infected site
⢠confusion, of sudden onset, particularly in older people
⢠drowsiness, irritability, poor appetite in children
Determining the duration of symptoms (e.g. cough, sore throat) and whether
the patientâs condition is improving or deteriorating
Manage patients expectations & refer patients to the GP only when absolutely
necessary (80% of antibiotics prescribed in primary care)
45. The role of community pharmacists in
antimicrobial stewardship
Counsel patients on appropriate antibiotic use when
prescribed
Counsel patients on adverse effects
Counsel patients on antibiotic resistance, as appropriate
Recommend symptomatic therapy for non-vulnerable
patients
46. The role of community pharmacists in
antimicrobial stewardship
Counsel patients on appropriate antibiotic use when
prescribed
Counsel patients on adverse effects
Counsel patients on antibiotic resistance, as appropriate
Recommend symptomatic therapy for non-vulnerable
patients
47. Counselling patients on appropriate
antibiotic use
Pharmacists are ideally placed to advise patients on
appropriate antibiotic use
Remember the mnemonic FRAIS
F Finish the course
R Regular intervals (e.g. 6-hourly, 8-hourly, etc)
A After, with or before food
I Interactions
S Side effects
Benefit of behind delayed/post-dated prescriptions
48. The role of community pharmacists in
antimicrobial stewardship
Counsel patients on appropriate antibiotic use when
prescribed
Counsel patients on adverse effects
Counsel patients on antibiotic resistance, as appropriate
Recommend symptomatic therapy for non-vulnerable
patients
49. Counselling patients on adverse effects
and how to avoid them
Common, mild, side effects of antibiotics include sickness, diarrhoea, bloating &
indigestion, abdominal pain and loss of appetite.
Less frequent is an allergic response may include rash, more serious is swelling of
the face and tongue and difficulty in breathing.
Clostridium difficile may be the cause of antibiotic-associated diarrhoea. Important
to be familiar with the symptoms, the antibiotics commonly associated with it and
its diagnosis and management
Antibiotics, often referred to as âthe 4Csâ are ciprofloxacin (quinolones), co-
amoxiclav (broad spectrum penicillins,) clindamycin and (3rd generation)
cephalosporins
Dont to sell or advise to take anti-spasmodics, e.g. loperamide as these agents can
increase the severity and length of disease due to the prolonged contact time of C
difficile toxins in the colon
50. The role of community pharmacists in
antimicrobial stewardship
Counsel patients on appropriate antibiotic use when
prescribed
Counsel patients on adverse effects
Counsel patients on antibiotic resistance, as appropriate
Recommend symptomatic therapy for non-vulnerable
patients
51. Counselling patients on resistance and
how to avoid this
Explain what antimicrobial resistance is and
how it occurs
A patient prescribed an antibiotic for a
respiratory or urinary tract infection can
exhibit bacterial resistance to that antibiotic
for < 12 months
The more often a patient is given a course of
antibiotics, the more likely the patientâs
bacteria will develop multiple or ongoing
resistance
52. The role of community pharmacists in
antimicrobial stewardship
Counsel patients on appropriate antibiotic use when
prescribed
Counsel patients on adverse effects
Counsel patients on antibiotic resistance, as appropriate
Recommend symptomatic therapy for non-vulnerable
patients
53. ⢠manage patients expectations & refer patients to the
GP only when absolutely necessary
⢠educate patients on the typical duration of an
infection â
acute otitis media â 4 d;
common cold - 1.5 wk;
acute rhinosinusitis 2.5 wk;
acute cough/acute bronchitis â 3 wk
⢠promote symptomatic relief â e.g. drinking plenty of fluids,
resting, pain relief and symptom control
⢠where ever possible supply written information to support
consultation
Counselling non-vulnerable* patients
*patients who need to be referred to a GP include those at risk of serious complications on account of pre-
existing co-morbidity, such as cystic fibrosis, significant heart, lung, renal, liver or neuromuscular disease,
those who are immunosuppressed, and children born prematurely
60. Welcome back
Dr Cliodna McNulty, Head, PHE Primary Care Unit
& Consultant Medical Microbiologist, and Honorary
Visiting Professor Cardiff University, National
Infection Service, Public Health England
62. Who is Tim Finnigan???
⢠Married, two children (grown up)
63. Who is Tim Finnigan???
⢠Married, two children (grown up)
⢠Likes running up hills and likes a pint
⢠30 years R&D in Food and Drink
⢠PhD Canola protein, Government food research, APV,
General Foods and...
64. IâM HERE IN PART TO TELL
âTHE QUORN STORYâ BUT
ONLY IN THE CONTEXT OFâŚ..
ďą AS AN ILLUSTRATION OF WHY WE NEED HEALTHY NEW PROTEINS WITH A
LOW ENVIRONMENTAL IMPACT
ďą AND THE GOOD NEWS THAT âIT CAN BE DONEâ
65. The 1960s was a time of
huge achievements...
The context
67. A man with a big idea
Inter-generational equity
68. âQuorn âŚ.began by
taking the original
fungi found in soil and
domesticating it in the
same way that our
ancestors did with
many plants.â
Spector, T (2015) The Diet Myth. Weidenfield
and Nicholson pp 137
Quorn has many influential advocates
68
70. + a large number of ducks, rabbits, horses, turkeysâŚ
..3 camels and one unfortunate mule
Chickens 110,000
Pigs 2,630
Sheep 922
Goats 781
Cows 557
The scale of livestock production is driven by our desire
for cheaper and more plentiful meat, but there are damaging
consequences, which at the moment are forecast only to intensify
The current contextâŚ
73. Challenge Consequence
To feed 9bn in 2050 FAO say we need a 60% increase in food production
some of the true costs of cheap and plentiful animal protein
Our demand for ever cheaper and more plentiful meat has
a number of potentially devastating consequencesâŚ
73
76. Challenge Consequence
To feed 9bn in 2050 FAO say we need a 60% increase in food production
some of the true costs of cheap and plentiful animal protein
Our demand for ever cheaper and more plentiful meat has
a number of potentially devastating consequencesâŚ
76
ďą THERAPEUTIC (disease
treatment)
ďą PROPHYLACTIC (disease
prevention)
ďą GROWTH PROMOTION
http://www.soilassociation.org/LinkClick.aspx?fileticket=H7srxwglZ-s%3d&tabid=313
77.
78. For most of us itâs a real surprise to learn that
antibiotics are used so freely in animal production
80% ANTIBIOTICS PRODUCED IN THE USA FED TO ANIMALS
AS OUR DEMAND FOR CHEAPER AND PLENTIFUL MEAT RISES SO WILL THE USE OF
ANTIBIOTICS IN INDUSTRIAL ANIMAL PRODUCTION
79. Six ways we have undermined a wonder drug
http://s.telegraph.co.uk/graphics/projects/antibiotic-resistance/
Agriculture
Globally more than 70 per cent
of antibiotics are used in animal
agriculture including some of the
most potent antibiotics
available. In more than 100
countries antibiotics are
routinely added to animal feed
to promote growth. So-called
mega farms, intensive meat and
poultry farms where diseases
can sweep through herds, are
blamed in particular for overuse
Aquaculture
Intensive aquaculture (shrimp
and fish farming) has led to
growing problems with
antibiotics routinely used to
treat diseases. The industry
supplies the world with 110
million metric tonnes of food
fish per year. 75 per cent of the
antibiotics fed to fish are
excreted back into the water
Veterinary
In Britain the veterinary sector
has been criticised for
irresponsible prescription of
antibiotics, as vets can profit by
selling the same drugs they
prescribe. The government does
not track the use of veterinary
antibiotics in detail, with the
main data available the total
annual tonnage of antibiotics
sold. In 2012, 409 tonnes of
antibiotics were prescribed by
vets in Britain
Soil
Many antibiotics are non bio-
degradable and can persist in
high concentrations in soil for a
long time. An estimated 70
million tonnes of animal manure
waste is spread on to agricultural
land each year in Britain. Crops
can take up substantial amount
of antibiotics by the roots.
Antibiotics are also sprayed on
to crops, such as high value fruit
trees, to prevent bacterial
diseases.
Profit
Only four major pharmaceutical
companies are left in the
development of antibiotics.
Antibiotics are not as profitable
as other drugs taken for chronic
conditions. A successful course
of antibiotics takes only a few
days, unlike diseases such as
diabetes and blood pressure
where drugs can be taken for
years.
80. Italy, 2013
EFSA: âOvercrowding is a risk factor for disease
expression and other causes of poor welfare
and should be avoidedâ
Regular antimicrobial use facilitates high animal densities:
The Lancet Infectious Diseases Commission, 2013
81. ⢠âUrgent action is needed to ... reduce antibiotic usage in animal
husbandryâ, WHO, 2014
⢠âUse of antibiotics as growth promoters should be banned worldwide as
has happened in the EUâ: The Lancet Infectious Diseases Commission, 2013
⢠âRoutine preventative use of antibiotics is unacceptableâ UK AMR Strategy:
Annual progress report and implementation plan, December 2014
âfailure to address antibiotic
overuse in agriculture and
its role in drug resistance is
like trying to stop lung
cancer without factoring in
smokingâŚ..â
82.
83. Challenge Consequence
To feed 9bn in 2050 FAO say we need a 60% increase in food production
some of the true costs of cheap and plentiful animal protein
Our demand for ever cheaper and more plentiful meat has
a number of potentially devastating consequencesâŚ
83
84. Challenges for a scalable meat based
sustainable food future
Our biggest lever globally is to eat less meat
85. New FAO report quantifies the cost of industrial livestock
production to the environment
86. THE No 1 CONTRIBUTER
ďą 1/3rd water use
ďą 18% -30% of global GHG emissions
ďą 45% of all land
ďą 91% of rainforest destruction to date (1 acre per second)
ďą Species loss
ďą Ocean deadzones
ďą Habitat destruction
ďą The rise of the superbug
ďą Micronutrient depletion
ďą Unaccounted costs of poor health and environmental impact
ďą Animal welfare and cruelty on an unprecedented scale
All the evidence is there to see
87. âThe need for new
business models that help
address the 9bn challenge
- including a healthy new
protein with a lower
environmental impactâŚ.â
Prof. Alan Knight Single Planet Living
Big steps toward small footprints
88. âFor all Mankindâs supposed
accomplishments, his continued
existence is completely dependent
on six inches of topsoil and the
fact that it rainsâŚ..â
94. Facts & Figures
41.7 million NHS
prescriptions for oral
antibiotics dispensed in
the primary care
setting
GDPs account for 9%
Health & Social Care
Information Centre, 2015
95. Facts & Figures
66.6% of dental
prescriptions are for
antibiotics
Health & Social Care
Information Centre, 2015
Amoxicillin Caps 500mg
One to be taken three times daily
Mitte 15
Dr J Doe
AnyTown Dental Practice
15 The High Street
AnyTown
4/11/14
96. Antibacterial drugs prescribed by
dentists, 2014
Antibiotic No of items % of all
antibacterials
Penicillins 2,443,111 66.1
Metronidazole 1,044,848 28.3
Macrolides 166,462 4.5
Clindamycin 18,360 0.5
Cephalosporins 14,109 0.4
Tetracyclines 9,129 0.2
Total 3,696,019 100
Health & Social Care Information Centre, 2015
98. Dental prescribers in primary care
Approx. 35,000
dentists working in
general dental practice
BDA âState of general practiceâ,
2013
99. Dental prescribers in primary care
11,000 dentists in
solely private practice
BDA âState of general practiceâ,
2013
100. Dental prescribers in primary care
23,947 working in NHS
practice with only 11%
totally NHS
HSCIC, 2015 & BDA âState of
general practiceâ, 2013
101. Dental prescribers in primary care
30 million patients
seen in last 24 months
within NHS general
practice
HSCIC, 2015
102. Dental prescribing in primary care
Average NHS dentist
writes 155 prescriptions
for antibiotics each
year
103. Dental prescribing in primary care
1 in 4 patients treated
in primary dental care
received a prescription
for antibiotics
104. Antibiotic use link to AMR
The strength of the
selective pressure (i.e. the
rate of drug consumption)
is intimately and positively
associated with the rate of
development of resistance
Levin et al. Clinical Infectious
Diseases, 1997
Costelloe et al. BMJ, 2010
105. Antibiotic use link to AMR
Consumption major
driver for development
of resistance
Higher rates of
resistance seen where
higher rates of
prescribing
106. Antimicrobial resistance & dentistry
34% of bacterial
isolates from dental
abscesses resistant to
penicillin
Kuryama et al. Oral Microbiol
Immunol, 2007
107. Antimicrobial resistance & dentistry
10% of patients had
MRSA in the oral cavity
McCormack et al. Am J Infect
Control, 2015
43% of oral
Streptococci in children
resistant to amoxicillin
Salako et al. Spec Care Dentist,
2007
108. Antibiotic resistance & oral infections
36% of endodontic pus
aspirates were positive
for antibiotic resistant
genes
More than one resistant
gene was detected
Rocas et al. Archives of Oral
Biology, 2013
109. Antibiotic resistance & oral infections
Endodontic infections
harboured resistance
genes for penicillins,
tetracycline and
erythromycin
Rocas et al. Archives of Oral
Biology, 2013
110. AMR and periodontal patients
â74% of periodontal
patients have
subgingival pathogens
resistant to either
doxycycline, amoxicillin
or metronidazoleâ
Rams et a. J Perio, 2014
114. Management of bacterial infections
Antibiotics only used as an
adjunct to removal of the cause
and
temperature is elevated, there
is systemic spread and lymph
gland involvement
119. Research on therapeutic prescribing
Non-clinical factors %
Patient expectation of a prescription 8.0
Pressure of time and workload 30.3
Patientâs social history 8.2
Uncertainty of diagnosis 47.2
Where treatment has to be delayed 72.5
Palmer et al. BDJ, 2000
121. GDPs reasons for prescribing during a
clinical audit Palmer et al. BDJ, 2001
122. GDPs reasons for prescribing during a
clinical audit
Reason for prescribing %
Localised fluctuant swelling 31
Gross diffuse swelling 16
Pain without presence of infection >50
Uncertainty of diagnosis 4
Treatment had to be delayed 10
Patient going away/in case of problems 1.7
Failed LA/unco-operative patient 1
Palmer et al. BDJ, 2001
123. Antibiotic prescribing â a cross sectional
study in general dental practice
57% of patients with pain or infections received
antibiotics
Only 19% of antibiotics were prescribed within
existing guidelines
Time pressures predictive of antibiotic prescribing
in the absence of infection
Cope et al. Community Dent Oral Epidemiol, 2015
124. FDs reasons for prescribing antibiotics
in a clinical audit Palmer et al. Prim Dent Care, 2004
125. FDs reasons for prescribing antibiotics
in a clinical audit
Reason for prescribing Number
Localised fluctuant swelling 163
Gross diffuse swelling 114
Elevated temperature/evidence of
systemic spread
86
Pain 222
Prophylaxis for surgery 50
Palmer et al. Prim Dent Care, 2004
126. Results of a prescription study
Wide variations in doses used
Incorrect frequencies present
in 5% of prescriptions
Duration for most antibiotics
ranged from 3 days to 21 days
Palmer et al. JAC, 2000
127. Analysis of management of patients in
an out-of-hours clinic
Retrospective analysis
of record cards (1472)
Reason for
attendance/diagnosis
Clinical management
Tulip and Palmer, BDJ, 2008
128. Analysis of management of patients in
an out-of-hours clinic
Over 80% had a dental
abscess
50% prescribed
antibiotics without any
definitive treatment
Tulip and Palmer. BDJ, 2008
129. Dental antibiotic prescribing in acute
care hospitals
63% of dental and oral surgery
patients were prescribed
antibiotics
5% had more than one antibiotic
13% had more than two antibiotics
Kanerva et al. JAC, 2007
130. Dental prescribing in paediatric
departments of three dental hospitals
Only 28% of
prescriptions issued in
first audit cycle were
appropriate
Yesudian et al. BDJ, 2015
131. Dental prescribing in paediatric
departments of three dental hospitals
Errors in prescription
writing were evident
e.g. no signature,
duration, quantity
Yesudian et al. BDJ, 2015
132. Dental prescribing in paediatric
departments of three dental hospitals
Some improvements in
appropriateness were
achieved by
educational
intervention
Yesudian et al. BDJ, 2015
133. Patient compliance to antibiotic
prescriptions
40% did not remember receiving
instructions
67% did not comply with
prescription
Blinder et al. Int J Oral Maxillofac Surg, 2001
134. Patient compliance to antibiotic
prescriptions
43% took more, 31% took less
4% who had no prescription took
antibiotics anyway
Blinder et al. Int J Oral Maxillofac Surg, 2001
135.
136. First published in 2000
Aim to promote prudent
prescribing and
stewardship
Updated as evidence arises
In harmony with BNF
138. Assessment of the patient
Comprehensive medical and dental history
Presence of fever, malaise, fatigue, dizziness
Measuring pulse and temperature
Defining nature, location and extent of swelling
Identifying the cause of infection
Reproduced with kind permission of FGDP(UK)
139. Indications for referral
Septicaemia - temperature above 39.5°C
Spreading cellulitis
Swellings that compromise airway, difficulty in
swallowing or eye closure
Dehydration
Significant trismus due to infection
Failure to respond to treatment
Uncooperative patient
Reproduced with kind permission of FGDP(UK)
140. Clinical management
Treatment options to remove cause of infection
When to prescribe antimicrobials
What antimicrobials to prescribe
Patient follow up and when to stop antimicrobials
How to manage failed resolution of infection
Reproduced with kind permission of FGDP(UK)
141. European Antibiotic Awareness Day
Lots of dentists use at
least one
Share participation in a
message
React with a campaign
Use of thunderclap
146. Press release 30/09/2015
The Faculty of General Dental Practice UK (FGDP(UK)) welcomes the
update to NICE guidance on prophylaxis against infective endocarditis
and supports its recommendation that no changes be made to the
original guidance published in 2008.
The FGDP(UK)âs guidelines Antimicrobial Prescribing For General
Dental Practitioners reflect the NICE guidance and with the
increasing problem of antimicrobial resistance provide evidence
based guidance for prudent prescribing and antimicrobial
stewardship. This is freely available to view online on the FGDP(UK)
website.
The FGDP(UK) will again be actively supporting European Antibiotic
Awareness Day on 18 November and Public Health Englandâs
Antibiotic pledge campaign in the same month.
http://www.fgdp.org.uk/content/news/fgdpuk-supports-nice-decision-on-guidance-for-prop.ashx
147. Press release 17/10/2015
âThe FGDP(UK) supports a report by the Centre
for Disease Dynamics, Economics and Policy in
Washington DC, published this week in the
Lancet (15/10/15), which highlights the
detrimental overuse of antibiotics, the dangers of
inappropriate use, and what steps can be taken to
keep them working.â
http://www.fgdp.org.uk/content/news/fgdpuk-press-release-
antibiotic-resistance.ashx
148. Our message this year asks dentists to pledge
âTo make more time to manage infections and
only prescribe antibiotics in line with published
guidelines.â
149. Press release 9/11/2015
Join in the Thunderclap to keep antibiotics
working
The Faculty of General Dental Practice (UK) is asking dentists and dental care
professionals to take part in a âThunderclapâ to promote more prudent use of
antibiotics. Dentists have a significant role to play in helping to slow the global
development of antibiotic resistance, and the Faculty is keen to highlight the
problem.
FGDP(UK), whose guidelines Antimicrobial Prescribing for General Dental
Practitioners are available for free online, has joined forces for the second year
with the Association of Clinical Oral Microbiologists (ACOM) and the British
Society for Antimicrobial Chemotherapy (BSAC) to create a Thunderclap,
which harnesses individualsâ social media networks to spread messages.
http://www.fgdp.org.uk/content/news/pledge-to-keep-antibiotics-working.ashx
150.
151. How will FGDP(UK) tackle the
challenge of AMR in the future?
Promote prudent
prescribing and
stewardship through
online guideline and
journal
152. How will FGDP(UK) tackle the
challenge of AMR in the future?
Collaborate to
highlight AMR and
judicious use of
antimicrobials at
every opportunity
153. How will FGDP(UK) tackle the
challenge of AMR in the future?
Help to develop a
freely available audit
tool for dental
practitioners
154. How will FGDP(UK) tackle the
challenge of AMR in the future?
Promote prudent
prescribing and
stewardship
throughout teaching
programmes
155. IMPLEMENTING START
SMART AND FOCUS IN
PRACTICE â A CASE
STUDY
Danielle Stacey
Specialist Antimicrobial Pharmacist
Dudley Group NHS Foundation Trust
156. Dudley Group NHS Foundation Trust
⢠Serves a population of 450,000 across Dudley and areas
of Sandwell, South Staffs and Wyre Forest
⢠District General
⢠Provides specialist
services to Black
Country and West
Midlands
157. Elements of Antimicrobial Stewardship
ExpertiseLeadership
Interventions Monitoring
EducationReporting
158. First steps
⢠Start Smart then Focus toolkit first published in November
2011
⢠Antimicrobial Steering Group established
⢠Online antibiotic guidelines and credit card published
⢠Restricted formulary introduced to reduce high-risk broad
spectrum antibiotics
⢠Antibiotic usage monitoring began
⢠Quarterly Point prevalence surveys started
160. Issues Identified for Improvement
⢠Adherence to guidelines
⢠Elements of Start Smart and Focus
⢠Documentation of indication
⢠Documentation of duration/date for review
⢠High IV antibiotic usage
⢠Duration of antibiotic course
⢠Underpinning all of this: Education and Training
163. Reducing duration of IV and overall
course length
⢠New drug chart â 72 hr review banner
⢠Drug chart update â duration and micro approved box
added
⢠Further update â indication box added
165. Feedback of point prevalence surveys
⢠After new drug charts introduced, improvements in results
became static
⢠What will make these improve?
⢠Educational outreach
⢠Rolling programme to visit every speciality 6 monthly
⢠Feedback on C.diff cases and apportionment outcomes
166. Did it make a difference?
⢠Documentation of duration still 55-60%
⢠Indication rose from 60% to 70% after first round of
feedback visits
⢠Up to 78% after second round of visits
⢠Highest result in West Midlands Region!
⢠C.diff cases apportioned due to lapses in Abx prescribing
⢠34% cases Trust apportioned in 2014-15
⢠18% cases Trust apportioned in 2015-16 so far
167. Reducing duration of IV and overall
course length
⢠Improved documentation has not reduced usage
168. Ensuring Start Smart and Focus
⢠Are antimicrobial prescribing policies and guidelines being
followed?
⢠Barriers
⢠Staff time to collect data
⢠Ownership of results
⢠Feedback of results
169. Adherence Audits
⢠Mandatory audit â Trust audit programme
⢠Medic led
⢠20 patients per speciality annually
⢠Each speciality produced report with recommendations
⢠Discussed at speciality meetings and Trust audit meeting
â see others results!!
170. Adherence audit results
Trust standard Target Result
Indication documented
in medical notes
100% 80%
Name documented in
medical notes
100% 77%
Duration documented
on prescription chart
100% 63%
Compliance with Trust
guidelines
90% 75%
If no: on microbiology
advice?
90% 22%
⢠Identified 75% compliance with guidelines due to no guidelines for some
indications â worked with specialities to produce guidelines
⢠2015 re-audit in progress â including 48hr Review
171. Education and Training
⢠Every doctor, nurse and pharmacist has antimicrobial
induction
⢠Mandatory training every 3 years â e-learning package
⢠Better training, better care â junior doctors
172. New initiatives
⢠Attending audit meetings to present results â league
tables!
⢠Junior doctor liasons â feedback updates to guidelines,
problems in practice, errors
⢠Two way feedback
⢠Start Smart then Focus â peer review
⢠48 hour review ward rounds and weekend planning
176. Chairs concluding comments
Dr Cliodna McNulty, Head, PHE Primary Care Unit
& Consultant Medical Microbiologist, and Honorary
Visiting Professor Cardiff University, National
Infection Service, Public Health England
177. Developed by Public Health England
National Awards
May 2016, Date and Venue tbc
Categories include:
Staff engagement: How have staff promoted Antibiotic Guardian and stewardship within their
organisation?
Community: How has your organisation worked within the community to highlight Antibiotic Guardian?
Prescribing: How has your organisation tackled prescription and prescribing antibiotics effectively?
Innovation: Tell us how you have demonstrated innovation to address Antimicrobial Resistance?
Antibiotic Stewardship: How have you improved or measured antibiotic usage in your area or
community?
AMS Research: How have you demonstrated development of research to support
Antimicrobial Stewardship?
For details of how to apply please visit
www.antibioticguardian.com
178. Developed by Public Health England
Why attend?
⢠Gain guidance on effective prescribing methods
⢠Hear the latest information on antimicrobial stewardship from leading experts
⢠Collaborate with fellow health professionals
⢠Receive resources to promote Antibiotic Stewardship in your workplace
Educational Roadshow Series
October 29th- Leeds
November 18th- Birmingham
February 24th-London